Skip to main content

Advertisement

Log in

Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

The present paper shows how cinnamon extract (CE) consumption mitigates neuronal loss and memory impairment following traumatic brain injury (TBI), one of the world’s most common neurodegenerative diseases. TBI patients suffer short- and long-term behavioral, cognitive, and emotional impairments, including difficulties in concentration, memory loss, and depression. Research shows that CE application can mitigate cognitive and behavioral impairments in animal models for Alzheimer’s and Parkinson’s disease, whose pathophysiology is similar to that of TBI. This study builds on prior research by showing similar results in TBI mice models. After drinking CE for a week, mice were injured using our 70-g weight drop TBI device. For 2 weeks thereafter, the mice continued drinking CE alongside standard lab nutrition. Subsequently, the mice underwent behavioral tests to assess their memory, motor activity, and anxiety. The mice brains were harvested for immunohistochemistry staining to evaluate overall neuronal survival. Our results show that CE consumption almost completely mitigates memory impairment and decreases neuronal loss after TBI. Mice that did not consume CE demonstrated impaired memory. Our results also show that CE consumption attenuated neuronal loss in the temporal cortex and the dentate gyrus. Mice that did not consume CE suffered a significant neuronal loss. There were no significant differences in anxiety levels and motor activity between all groups. These findings show a new therapeutic approach to improve cognitive function and decrease memory loss after TBI.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Anderson RA, Leigh Broadhurst C, Polansky MM, Schmidt WF, Khan A, Flanagan VP, Schoene NW, Graves DJ (2004) Isolation and characterization of polyphenol type-a polymers from cinnamon with insulin-like biological activity. J Agric Food Chem 52(1):65–70

    CAS  PubMed  Google Scholar 

  • Anderson RA, Qin B, Canini F, Poulet L, Roussel AM (2013) Cinnamon counteracts the negative effects of a high fat/high fructose diet on behavior, brain insulin signaling and Alzheimer-associated changes. PLoS One 8(12):e83243

    PubMed  PubMed Central  Google Scholar 

  • Baratz R, Rubovitch V, Frenk H, Pick CG (2010) The influence of alcohol on behavioral recovery after MTBI in mice. J Neurotrauma 27(3):555–563

    PubMed  Google Scholar 

  • Baratz R, Tweedie D, Wang JY, Rubovitch V, Luo W, Hoffer BJ, Greig NH, Pick CG (2015) Transiently lowering tumor necrosis factor-Aα synthesis ameliorates neuronal cell loss and cognitive impairments induced by minimal traumatic brain injury in mice. J Neuroinflammation 12(1):45

    PubMed  PubMed Central  Google Scholar 

  • Belzung C, Griebel G (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Pp. 141–49 in Behavioural Brain Research. Vol. 125

  • Brahmachari S, Jana A, Pahan K (2009) Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol 183(9):5917–5927

    CAS  PubMed  Google Scholar 

  • Chen YF, Wang YW, Huang WS, Lee MM, Gibson Wood W, Leung YM, Tsai HY (2016) Trans-cinnamaldehyde, an essential oil in cinnamon powder, ameliorates cerebral ischemia-induced brain injury via inhibition of neuroinflammation through attenuation of INOS, COX-2 expression and NFκ-B signaling pathway. NeuroMolecular Med 18(3):322–333

    CAS  PubMed  Google Scholar 

  • Choe MC (2016) The pathophysiology of concussion. Curr Pain Headache Rep 20(6):42

    PubMed  Google Scholar 

  • Daneshvar DH, Riley DO, Nowinski CJ, McKee AC, Stern RA, Cantu RC (2011) Long-term consequences: effects on normal development profile after concussion. Phys Med Rehabil Clin N Am 22(4):683–700

    PubMed  PubMed Central  Google Scholar 

  • Dix SL, Aggleton JP (1999) Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition. Behav Brain Res 99(2):191–200

    CAS  PubMed  Google Scholar 

  • Dugoua JJ, Seely D, Perri D, Cooley K, Forelli T, Mills E, Koren G (2007) From type 2 diabetes to antioxidant activity: a systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol 85(9):837–847

    CAS  PubMed  Google Scholar 

  • Edut S, Rubovitch V, Schreiber S, Pick CG (2011) The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (MTBI). Psychopharmacology 214(4):877–889

    CAS  PubMed  Google Scholar 

  • Espejo EF (1997) Structure of the mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86(1):105–112

    Google Scholar 

  • Fleminger S, Oliver DL, Lovestone S, Rabe-Hesketh S, Giora A (2003) Head injury as a risk factor for Alzheimer’s disease: the evidence 10 years on; a partial replication. Journal of Neurology Neurosurgery and Psychiatry 74(7):857–862

    CAS  Google Scholar 

  • Frydman-Marom A, Levin A, Farfara D, Benromano T, Scherzer-Attali R, Peled S, Vassar R, Segal D, Gazit E, Frenkel D, Ovadia M (2011) Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer’s disease animal models. PLoS One 6(1):e16564

    CAS  PubMed  PubMed Central  Google Scholar 

  • Gende B, Liesel IF, Fritz R, Martin Javier E (2008) Antimicrobial activity of cinnamon (Cinnamomum Zeylanicum) essential oil and its main components against Paenibacillus larvae from argentine. Bulletin of Insectology 61(1):1–4

    Google Scholar 

  • Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, William Langston J (2006) Head injury and Parkinson’s disease risk in twins. Ann Neurol 60(1):65–72

    PubMed  Google Scholar 

  • Greve MW, Zink BJ (2009) Pathophysiology of traumatic brain injury. Mt Sinai J Med 76(2):97–104

    PubMed  Google Scholar 

  • Holm L, David Cassidy J, Carroll LJ, Borg J (2005) Summary of the WHO collaborating Centre for Neurotrauma Task Force on mild traumatic brain injury. J Rehabil Med 37(3):137–141

    PubMed  Google Scholar 

  • Khan A, Safdar M, Khan MMA, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215–3218

    PubMed  Google Scholar 

  • Levin HS, Diaz-Arrastia RR (2015) Diagnosis, prognosis, and clinical management of mild traumatic brain injury. The Lancet Neurology 14(5):506–517

    PubMed  Google Scholar 

  • Lighthall JW (1988) Controlled cortical impact: a new experimental brain injury model. J Neurotrauma 5(1):1–15

    CAS  PubMed  Google Scholar 

  • Lin LC, Wang MN, Tseng TY, Sung JS, Tsai TH (2007) Pharmacokinetics of (-)-epigallocatechin-3-gallate in conscious and freely moving rats and its brain regional distribution. J Agric Food Chem 55(4):1517–1524

    CAS  PubMed  Google Scholar 

  • Maas AIR, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. The Lancet Neurology 7(8):728–741

    PubMed  Google Scholar 

  • Manach C, Williamson G, Morand C, Scalbert A, Rémésy C (2005). Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. The American Journal of Clinical Nutrition 81(1 Suppl)

  • McAllister TW (2011) Neurobiological consequences of traumatic brain injury. Dialogues Clin Neurosci 13(3):287–300

    PubMed  PubMed Central  Google Scholar 

  • McInnes K, Friesen CL, MacKenzie DE, Westwood DA, Boe SG (2017) Mild traumatic brain injury (MTBI) and chronic cognitive impairment: a scoping review. PLoS One 12(4):e0174847

    PubMed  PubMed Central  Google Scholar 

  • McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H, Faden AL (1989) Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 28(1):233–244

    CAS  PubMed  Google Scholar 

  • Milman A, Rosenberg A, Weizman R, Pick CG (2005) Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 22(9):1003–1010

    CAS  PubMed  Google Scholar 

  • Momtaz S, Hassani S, Khan F, Ziaee M (2018) Cinnamon , a promising prospect towards Alzheimer ’ s disease. Pharmacol Res 130:241–258

    CAS  PubMed  Google Scholar 

  • Moppett IK (2007) Traumatic brain injury: assessment, resuscitation and early management. Br J Anaesth 99(1):18–31

    CAS  PubMed  Google Scholar 

  • Mustafa AG, Al-Shboul OA (2013) Pathophysiology of traumatic brain injury. Neurosciences 18(3):222–234

    PubMed  Google Scholar 

  • Ouattara B, Simard RE, Holley RA, Piette GJP, Bégin A (1997) Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol 37(2–3):155–162

    CAS  PubMed  Google Scholar 

  • Peterson DW, George RC, Scaramozzino F, Lapointe NE, Anderson RA, Graves DJ, Lew J (2009) Cinnamon extract inhibits tau aggregation associated with Alzheimer’s disease in vitro. J Alzheimers Dis 17(3):585–597

    CAS  PubMed  Google Scholar 

  • Rachmany L, Tweedie D, Rubovitch V, Yu Q-S, Li Y, Wang J-Y, Pick CG, Greig NH (2013) “Cognitive impairments accompanying rodent mild traumatic brain injury involve P53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α” edited by B. K. Harvey. PLoS ONE 8(11):e79837

    PubMed  PubMed Central  Google Scholar 

  • Rao PV, and Gan SH (2014). Cinnamon: a multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine : ECAM 2014

  • Russell RM, Paiva SAR (1999) β-Carotene and other carotenoids as antioxidants. J Am Coll Nutr 18(5):426–433

    PubMed  Google Scholar 

  • Schaffer S, Halliwell B (2012) Do polyphenols enter the brain and does it matter? Some theoretical and practical considerations. Genes and Nutrition 7(2):99–109

    CAS  PubMed  Google Scholar 

  • Shaltiel-Karyo R, Davidi D, Frenkel-Pinter M, Ovadia M, Segal D, Gazit E (2012) Differential inhibition of α-synuclein oligomeric and fibrillar assembly in Parkinson’s disease model by cinnamon extract. Biochim Biophys Acta Gen Subj 1820(10):1628–1635

    CAS  Google Scholar 

  • Simiand J, Keane PE, Morre M (1984) The staircase test in mice: a simple and efficient procedure for primary screening of anxiolytic agents. Psychopharmacology 84(1):48–53

    CAS  PubMed  Google Scholar 

  • Slemmer JE, Zhu C, Landshamer S, Trabold R, Grohm J, Ardeshiri A, Wagner E, Sweeney MI, Blomgren K, Culmsee C, Weber JT, Plesnila N (2008) Causal role of apoptosis-inducing factor for neuronal cell death following traumatic brain injury. Am J Pathol 173(6):1795–1805

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yulug B, Kilic E, Altunay S, Ersavas C, Orhan C, Dalay A, Tuzcu M, Sahin N, Juturu V, Sahin K (2018) Cinnamon polyphenol extract exerts neuroprotective activity in traumatic brain injury in male mice. CNS Neurol Disord Drug Targets 17(6):439–447

    CAS  PubMed  Google Scholar 

  • Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, Pick CG (2003) Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118(4):949–955

    CAS  PubMed  Google Scholar 

  • Zohar O, Rubovitch V, Milman A, Schreiber S, Pick CG (2011) Behavioral consequences of minimal traumatic brain injury in mice. Acta Neurobiol Exp 71(1):36–45

    Google Scholar 

Download references

Acknowledgements

This research was supported in part by the Ari and Regine Aprijaskis Fund at Tel-Aviv University and the Dr. Miriam and Sheldon G. Adelson Chair for the Biology of Addictive Diseases in Tel-Aviv University, Tel-Aviv, Israel.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chaim G. Pick.

Ethics declarations

The Sackler Commission on Animal Experimentation approved the trial protocol M-14-050, M-15-011, in line with the Guidelines for Animal Experimentation of the National Institutes of Health (DHEW publication 85-23, revised, 1995).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qubty, D., Rubovitch, V., Benromano, T. et al. Orally Administered Cinnamon Extract Attenuates Cognitive and Neuronal Deficits Following Traumatic Brain Injury. J Mol Neurosci 71, 178–186 (2021). https://doi.org/10.1007/s12031-020-01688-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-020-01688-4

Keywords

Navigation